-
Network Pharmacology and Experimental Validation of the Effects of Shenling Baizhu San, Quzhi Ruangan Fang and Gexia Zhuyu Tang on the Intestinal Flora of Rats with NAFLD
16 Apr 2025 23:49 GMT
… the occurrence, development, and treatment of NAFLD.95 … the problem of metabolic diseases. Disturbances in gut … disentangling microbial signatures from metabolic disorders. Nat Rev Gastroenterol … database of systems pharmacology for drug discovery from herbal …
-
Pfizer axes controversial medication amid liver cancer fears
16 Apr 2025 21:25 GMT
… caused by the drug.
The pharmaceutical giant halted the … develop a weight loss pill.
The statement continued: 'Cardiovascular and metabolic diseases … a pipeline of investigational treatments that have the … , an anti-diabetic medication that also helps in …
-
Pfizer: Danuglipron development for a pill alternative to Ozempic canned after liver side effects recorded
16 Apr 2025 23:12 GMT
… halted development of an Ozempic-style pill after … to developing an offering for “cardiovascular and metabolic diseases including … trial to a scientific forum.
The dumping of the Ozempic-like-drug … comes as global pharmaceutical giants race …
-
Abu Dhabi's M42 partners with UK firm to develop AI-driven therapeutics for age-related diseases
16 Apr 2025 15:44 GMT
… developing AI-enabled therapeutics to advance the treatment … disease, neurodegeneration, and metabolic disorders are becoming increasingly prevalent … we discover and deliver drugs, bringing innovative, life … aim to identify novel drug targets and therapeutics, …
-
Pfizer to discontinue development of danuglipron, an oral GLP─ receptor agonist for chronic weight management
16 Apr 2025 08:22 GMT
… NCT06568731) met key pharmacokinetic objectives and confirmed a … studies experienced potential drug-induced liver injury … discontinue development of the molecule.
“Cardiovascular and metabolic diseases … pipeline of investigational treatments that have the …
-
Preventing Onset and Development of Heart Failure With Preserved Ejection Fraction
15 Apr 2025 19:28 GMT
… in need of effective treatment. The team reports in … target to prevent and treat this life-threatening disease. … hearts from individuals with metabolic disorders and in mouse models … the onset and development of heart failure in metabolic disorders.
" …
-
Pfizer will end development of weight-loss pill over fears about its impact to the liver
15 Apr 2025 18:20 GMT
… pill to treat obesity.
The move comes after a patient in a trial … loss drugs taken twice a day.
Several companies are developing weight loss pills … development of an experimental oral drug targeting a different hormone.
“Cardiovascular and metabolic diseases …
-
Pfizer Discontinues Development of Investigational Oral GLP-1 for Weight Management
15 Apr 2025 16:26 GMT
… .1
“Cardiovascular and metabolic diseases, including obesity, remain … to discontinue the development of danuglipron, we … medications. However, one asymptomatic patient did experience drug … . Secondary endpoints included treatment-emergent adverse events ( …
-
Best Weight Loss Pills of 2025 Tested & Reviewed: Mitolyn Dietary Supplement
15 Apr 2025 16:02 GMT
… root of many metabolic disorders. Mitolyn' … pills that don't rely on synthetic chemicals or risky pharmaceutical … Prescription Medications (Ozempic, Wegovy, Mounjaro) Drugs like … Drug Administration (FDA). Mitolyn is not intended to diagnose, treat …
-
Challenges with developing nutritional recommendations to improve pregnancy outcomes
15 Apr 2025 13:22 GMT
… , UK
2MRC Metabolic Diseases Unit, Institute of … metabolic disorders continues to accelerate (fig 1).
Fig 1 Potential pathways of developmental … preventing early onset metabolic disease. This strategy … women who require drug treatment for gestational diabetes …